Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin

Haematologica

Volumn 90, Issue 1, 2005, Pages 137-139

  Crowther, Mark A ^a   Ageno, Walter ^b   Schnurr, Terri ^a   Manfredi, Elisa ^b   Kinnon, Krys ^a   Garcia, David ^c   Douketis, James D ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; VITAMIN K GROUP; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MALE; PERIOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; REFERENCE VALUES; TIME FACTORS; VITAMIN K; WARFARIN; WITHHOLDING TREATMENT;

EID: 13244270140     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002;108:3-13.
2. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med 2003;163:2469-73.